Results 171 to 180 of about 620,469 (268)

Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases

Human Vaccines & Immunotherapeutics, 2015
A. Narayana, A. Manoharan, M. S. Narayan, Sudarshan Mysore Kalappa, Gangaboraiah Biligumba, Ravish S Haradanahalli, A. Anand   +6 more
semanticscholar   +1 more source

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes. [PDF]

Hum Vaccin Immunother
Li J, Wu Z, Wu X, Wang Y, Shi L, Zhao D, Liang H, Mo Z, Cao S.   +8 more
europepmc   +1 more source

Seroepidemiological survey to cell culture rabies vaccines (CCRV) in Brazil. [PDF]

One Health
da Silva RI, Chaves LB, Dos Ramos Silva S, Katz ISS, Fernandes ER, Neto RC, Padovani CR, Modolo JR, Soares Magalhaes RJ, Crompton H, Victoria C.   +10 more
europepmc   +1 more source

A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody. [PDF]

Hum Vaccin Immunother, 2020
Gairola S, Gautam M, Waghmare S.
europepmc   +1 more source

The advent of human diploid cell rabies vaccine: impact on vaccine utilization in New Mexico.

, 1981
J M Mann, Richard E. Hoffman, O J Rollag, L Bartol, Margie Burkhart   +4 more
openalex   +1 more source

A Step Forward in the Quality Control Testing of Inactivated Rabies Vaccines — Extensive Evaluation of European Vaccines by Using Alternative Methods to the In Vivo Potency Tests

Alternatives to laboratory animals : ATLA, 2015
A. Servat, Sébastien Kempff, Valère Brogat, Estelle Litaize, J. Schereffer, F. Cliquet   +5 more
semanticscholar   +1 more source

EXPOSURE TIME OF ORAL RABIES VACCINE BAITS RELATIVE TO BAITING DENSITY AND RACCOON POPULATION DENSITY [PDF]

, 2004
Bradley F. Blackwell, Thomas W. Seamans, Randolph J. White, Zachary J. Patton, Rachel M. Bush, Jonathan D. Cepek   +5 more
openalex   +1 more source

The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania

Vaccine, 2019
Joel Changalucha, R. Steenson, E. Grieve, S. Cleaveland, T. Lembo, K. Lushasi, G. Mchau, Z. Mtema, M. Sambo, A. Nanai, N. Govella, Angel Dilip, Lwitiko Sikana, Francesco Ventura, K. Hampson   +14 more
semanticscholar   +1 more source

The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study

Travel Medicine and Infectious Disease
Background: The combination of passive immune agents (human rabies immune globulin (HRIG) and equine rabies antiserum (ERA)) with vaccines are effective measures for preventing the onset of rabies post exposure. However, ERA and HRIG have potential risks
Yin Yin, Min Jia, Yufeng Li, Wei Zhao, Shuhong Chen, Peiyuan Huo, Qinghua Zhao, Lan Yu, Cha Wang, Yirui Ma, Meixia Wang, Jing Zhang   +11 more
doaj  

Adverse reactions associated with a Fuenzalida-Palacios rabies vaccine: a quasi-experimental study [PDF]

, 2004
Rosuíta Fratari Bonito, Neide Mattar de Oliveira, Sérgio de Andrade Nishioka   +2 more
openalex   +1 more source